{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:11:12Z","timestamp":1760609472473,"version":"3.40.3"},"publisher-location":"Cham","reference-count":82,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031054594"},{"type":"electronic","value":"9783031054600"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-05460-0_8","type":"book-chapter","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T14:02:49Z","timestamp":1661608969000},"page":"109-118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mitochondrial Dysregulation and the Influence in Neurodegenerative Diseases"],"prefix":"10.1007","author":[{"given":"Giuliana S.","family":"Zuccoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Corasolla","family":"Carregari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,28]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1113\/jphysiol.2002.035196","volume":"548","author":"G David","year":"2003","unstructured":"David, G., & Barett, E. F. (2003). Mitochondrial Ca2+ uptake prevents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals. The Journal of Physiology, 548, 425\u2013438.","journal-title":"The Journal of Physiology"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10545-011-9382-9","volume":"35","author":"AI Jonckheere","year":"2012","unstructured":"Jonckheere, A. I., Smeitink, J. A. M., & Rodenburg, R. J. T. (2012). Mitochondrial ATP synthase: Architecture, function and pathology. Journal of Inherited Metabolic Disease, 35, 211\u2013225.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-012148660-0\/50004-4","volume-title":"From molecules to networks","author":"PJ Magistretti","year":"2004","unstructured":"Magistretti, P. J. (2004). Brain energy metabolism. In From molecules to networks (pp. 67\u201389). Elsevier. https:\/\/doi.org\/10.1016\/B978-012148660-0\/50004-4"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41536-020-00107-x","volume":"5","author":"P Norat","year":"2020","unstructured":"Norat, P., et al. (2020). Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. npj Regenerative Medicine, 5, 1\u20139.","journal-title":"npj Regenerative Medicine"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1113\/jphysiol.2011.212712","volume":"589","author":"M Picard","year":"2011","unstructured":"Picard, M., Taivassalo, T., Gouspillou, G., & Hepple, R. T. (2011). Mitochondria: Isolation, structure and function. The Journal of Physiology, 589, 4413\u20134421.","journal-title":"The Journal of Physiology"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/NEJM199509073331007","volume":"333","author":"D Johns","year":"1995","unstructured":"Johns, D., & Mitochondrial, R. (1995). DNA and disease. The New England Journal of Medicine, 333, 638\u2013644.","journal-title":"The New England Journal of Medicine"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1873-3468.12964","volume":"592","author":"PR Angelova","year":"2018","unstructured":"Angelova, P. R., & Abramov, A. Y. (2018). Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Letters, 592, 692\u2013702.","journal-title":"FEBS Letters"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.1201940","volume":"333","author":"DR Green","year":"2011","unstructured":"Green, D. R., Galluzzi, L., & Kroemer, G. (2011). Mitochondria and the autophagy\u2013inflammation\u2013cell death axis in organismal aging. Science (80-.), 333, 1109\u20131112.","journal-title":"Science (80-.)"},{"key":"8_CR9","first-page":"1","volume":"9","author":"JH Park","year":"2021","unstructured":"Park, J. H., & Hayakawa, K. (2021). Extracellular mitochondria signals in CNS disorders. Frontiers in Cell and Development Biology, 9, 1\u20139.","journal-title":"Frontiers in Cell and Development Biology"},{"key":"8_CR10","doi-asserted-by":"publisher","unstructured":"Kumari, R., Shekhar, N., Tyagi, S., & Thakur, A. K. (2021). Mitochondrial dysfunctions and neurodegenerative diseases: A mini-review. https:\/\/doi.org\/10.15406\/japlr.2021.10.00378","DOI":"10.15406\/japlr.2021.10.00378"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","volume":"39","author":"DC Wallace","year":"2005","unstructured":"Wallace, D. C. (2005). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annual Review of Genetics, 39, 359\u2013407.","journal-title":"Annual Review of Genetics"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.brainresrev.2005.03.004","volume":"49","author":"PH Reddy","year":"2005","unstructured":"Reddy, P. H., & Beal, M. F. (2005). Are mitochondria critical in the pathogenesis of Alzheimer\u2019s disease? Brain Research Reviews, 49, 618\u2013632.","journal-title":"Brain Research Reviews"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"119985","DOI":"10.1016\/j.lfs.2021.119985","volume":"285","author":"S Mani","year":"2021","unstructured":"Mani, S., et al. (2021). Mitochondrial defects: An emerging theranostic avenue towards Alzheimer\u2019s associated dysregulations. Life Sciences, 285, 119985.","journal-title":"Life Sciences"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","volume":"218","author":"HA Elfawy","year":"2019","unstructured":"Elfawy, H. A., & Das, B. (2019). Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies. Life Sciences, 218, 165\u2013184.","journal-title":"Life Sciences"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T., & Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443, 787\u2013795.","journal-title":"Nature"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/antiox6020025","volume":"6","author":"J Gao","year":"2017","unstructured":"Gao, J., et al. (2017). Abnormalities of mitochondrial dynamics in neurodegenerative diseases. Antioxidants, 6, 25.","journal-title":"Antioxidants"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger, B. N., & Dickson, D. W. (2017). Pathology of neurodegenerative diseases. Cold Spring Harbor Perspectives in Biology, 9, a028035.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4103\/1673-5374.322430","volume":"17","author":"F Rey","year":"2022","unstructured":"Rey, F., Ottolenghi, S., Zuccotti, G., Samaja, M., & Carelli, S. (2022). Mitochondrial dysfunctions in neurodegenerative diseases: Role in disease pathogenesis, strategies for analysis and therapeutic prospects. Neural Regeneration Research, 17, 754\u2013758.","journal-title":"Neural Regeneration Research"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014). The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis. Movement Disorders, 29, 1583\u20131590.","journal-title":"Movement Disorders"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mds.10305","volume":"18","author":"D Twelves","year":"2003","unstructured":"Twelves, D., Perkins, K. S. M., & Counsell, C. (2003). Systematic review of incidence studies of Parkinson\u2019s disease. Movement Disorders, 18, 19\u201331.","journal-title":"Movement Disorders"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., & Rocca, W. A. (2013). Incidence and pathology of synucleinopathies and tauopathies related to Parkinsonism. JAMA Neurology, 70, 859\u2013866.","journal-title":"JAMA Neurology"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden, S. K., et al. (2003). Incidence of Parkinson\u2019s disease: Variation by age, gender, and race\/ethnicity. American Journal of Epidemiology, 157, 1015\u20131022.","journal-title":"American Journal of Epidemiology"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V., & Lang, A. E. (2015). Parkinson\u2019s disease. Lancet, 386, 896\u2013912.","journal-title":"Lancet"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa, E., Wenning, G., & Poewe, W. (2006). The diagnosis of Parkinson\u2019s disease. Lancet Neurology, 5, 75\u201386.","journal-title":"Lancet Neurology"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 51, 745\u2013752.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B., et al. (2015). MDS clinical diagnostic criteria for Parkinson\u2019s disease. Movement Disorders, 30, 1591\u20131601.","journal-title":"Movement Disorders"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/archneurol.2010.194","volume":"67","author":"RN Alcalay","year":"2010","unstructured":"Alcalay, R. N., et al. (2010). Frequency of known mutations in early onset PD; implication for genetic counseling: The CORE-PD study. Archives of Neurology, 67, 1116\u20131122.","journal-title":"Archives of Neurology"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archneurol.2010.95","volume":"67","author":"KS Marder","year":"2010","unstructured":"Marder, K. S., et al. (2010). Predictors of Parkin mutations in early-onset Parkinson disease. Archives of Neurology, 67, 1\u20137.","journal-title":"Archives of Neurology"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W., et al. (2017). Parkinson disease. Nature Reviews Disease Primers, 3, 1\u201321.","journal-title":"Nature Reviews Disease Primers"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri, K. R., & Schapira, A. H. (2009). Non-motor symptoms of Parkinson\u2019s disease: Dopaminergic pathophysiology and treatment. Lancet Neurology, 8, 464\u2013474.","journal-title":"Lancet Neurology"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/sj.cdd.4402160","volume":"14","author":"AHV Schapira","year":"2007","unstructured":"Schapira, A. H. V. (2007). Mitochondrial dysfunction in Parkinson\u2019s disease. Cell Death and Differentiation, 14, 1261\u20131266.","journal-title":"Cell Death and Differentiation"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose, A., & Beal, M. F. (2016). Mitochondrial dysfunction in Parkinson\u2019s disease. Journal of Neurochemistry, 139, 216\u2013231.","journal-title":"Journal of Neurochemistry"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"G Monzio Compagnoni","year":"2020","unstructured":"Monzio Compagnoni, G., et al. (2020). The role of mitochondria in neurodegenerative diseases: The lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. Molecular Neurobiology, 57, 2959\u20132980.","journal-title":"Molecular Neurobiology"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez, P., et al. (2021). Disruption of mitochondrial complex I induces progressive parkinsonism. Nature, 599, 650\u2013656.","journal-title":"Nature"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal, M. F. (2005). Mitochondria take center stage in aging and neurodegeneration. Annals of Neurology, 58, 495\u2013505.","journal-title":"Annals of Neurology"},{"key":"8_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ana.410440207","volume":"44","author":"M Gu","year":"1998","unstructured":"Gu, M., Cooper, J. M., Taanman, J. W., & Schapira, A. H. V. (1998). Mitochondrial DNA transmission of the mitochondrial defect in Parkinson\u2019s disease. Annals of Neurology, 44, 177\u2013186.","journal-title":"Annals of Neurology"},{"key":"8_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","volume":"46","author":"ME Johnson","year":"2015","unstructured":"Johnson, M. E., & Bobrovskaya, L. (2015). An update on the rotenone models of Parkinson\u2019s disease: Their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology, 46, 101\u2013116.","journal-title":"Neurotoxicology"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"20704","DOI":"10.3390\/ijms160920704","volume":"16","author":"Y Luo","year":"2015","unstructured":"Luo, Y., Hoffer, A., Hoffer, B., & Qi, X. (2015). Mitochondria: A therapeutic target for Parkinson\u2019s disease? International Journal of Molecular Sciences, 16, 20704\u201320730.","journal-title":"International Journal of Molecular Sciences"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015). Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: From familial to sporadic disease. Trends in Biochemical Sciences, 40, 200\u2013210.","journal-title":"Trends in Biochemical Sciences"},{"key":"8_CR40","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/hmg\/ddt600","volume":"23","author":"K Stafa","year":"2014","unstructured":"Stafa, K., et al. (2014). Functional interaction of Parkinson\u2019s disease-associated LRRK2 with members of the dynamin GTPase superfamily. Human Molecular Genetics, 23, 2055\u20132077.","journal-title":"Human Molecular Genetics"},{"key":"8_CR41","doi-asserted-by":"publisher","first-page":"e9367","DOI":"10.1371\/journal.pone.0009367","volume":"5","author":"G Krebiehl","year":"2010","unstructured":"Krebiehl, G., et al. (2010). Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson\u2019s disease-associated protein DJ-1. PLoS One, 5, e9367.","journal-title":"PLoS One"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","volume":"364","author":"P Luoma","year":"2004","unstructured":"Luoma, P., et al. (2004). Parkinsonism, premature menopause, and mitochondrial DNA polymerase \u03b3 mutations: Clinical and molecular genetic study. Lancet, 364, 875\u2013882.","journal-title":"Lancet"},{"key":"8_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","volume":"454","author":"G Liu","year":"2009","unstructured":"Liu, G., et al. (2009). \u03b1-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neuroscience Letters, 454, 187\u2013192.","journal-title":"Neuroscience Letters"},{"key":"8_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S., et al. (2021). Alzheimer disease. Nature Reviews Disease Primers, 7, 1\u201321.","journal-title":"Nature Reviews Disease Primers"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","volume":"14","author":"PH Reddy","year":"2008","unstructured":"Reddy, P. H., & Beal, M. F. (2008). Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer\u2019s disease. Trends in Molecular Medicine, 14, 45\u201353.","journal-title":"Trends in Molecular Medicine"},{"key":"8_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03530.x","volume":"96","author":"PH Reddy","year":"2006","unstructured":"Reddy, P. H. (2006). Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer\u2019s disease. Journal of Neurochemistry, 96, 1\u201313.","journal-title":"Journal of Neurochemistry"},{"key":"8_CR47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe, D. J. (2001). Alzheimer\u2019s disease: Genes, proteins, and therapy. Physiological Reviews, 81, 741\u2013766.","journal-title":"Physiological Reviews"},{"key":"8_CR48","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang, X., et al. (2014). Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1842, 1240\u20131247.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"8_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","volume":"131","author":"V Shoshan-Barmatz","year":"2018","unstructured":"Shoshan-Barmatz, V., Nahon-Crystal, E., Shteinfer-Kuzmine, A., & Gupta, R. (2018). VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease. Pharmacological Research, 131, 87\u2013101.","journal-title":"Pharmacological Research"},{"key":"8_CR50","doi-asserted-by":"publisher","first-page":"S591","DOI":"10.3233\/JAD-2010-100336","volume":"20","author":"GE Gibson","year":"2010","unstructured":"Gibson, G. E., & Shi, Q. (2010). A mitocentric view of Alzheimer\u2019s disease suggests multi-faceted treatments. Journal of Alzheimer\u2019s Disease, 20, S591\u2013S607.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"8_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"UA Khan","year":"2014","unstructured":"Khan, U. A., et al. (2014). Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nature Neuroscience, 17, 304\u2013311.","journal-title":"Nature Neuroscience"},{"key":"8_CR52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman, E. M., et al. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proceedings of the National Academy of Sciences of the United States of America, 101, 284\u2013289.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","volume":"1415","author":"PH Reddy","year":"2011","unstructured":"Reddy, P. H. (2011). Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer\u2019s disease. Brain Research, 1415, 136\u2013148.","journal-title":"Brain Research"},{"key":"8_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0197-4580(00)83289-3","volume":"21","author":"G Perry","year":"2000","unstructured":"Perry, G., et al. (2000). Mitochondrial abnormalities in Alzheimer disease. Neurobiology of Aging, 21, 213.","journal-title":"Neurobiology of Aging"},{"key":"8_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12035-010-8109-5","volume":"41","author":"A Eckert","year":"2010","unstructured":"Eckert, A., Schulz, K. L., Rhein, V., & G\u00f6tz, J. (2010). Convergence of amyloid-\u03b2 and tau pathologies on mitochondria in vivo. Molecular Neurobiology, 41, 107\u2013114.","journal-title":"Molecular Neurobiology"},{"key":"8_CR56","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3390\/cells10092380","volume":"10","author":"P Sinclair","year":"2021","unstructured":"Sinclair, P., Baranova, A., & Kabbani, N. (2021). Mitochondrial disruption by amyloid beta 42 identified by proteomics and pathway mapping. Cell, 10, 2380.","journal-title":"Cell"},{"key":"8_CR57","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1007\/s00018-018-2825-9","volume":"75","author":"C Guimas Almeida","year":"2018","unstructured":"Guimas Almeida, C., Sadat Mirfakhar, F., Perdig\u00e3o, C., & Burrinha, T. (2018). Impact of late-onset Alzheimer\u2019s genetic risk factors on beta-amyloid endocytic production. Cellular and Molecular Life Sciences, 75, 2577\u20132589.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"8_CR58","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.143.3.777","volume":"143","author":"A Ebneth","year":"1998","unstructured":"Ebneth, A., et al. (1998). Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer\u2019s disease. The Journal of Cell Biology, 143, 777\u2013794.","journal-title":"The Journal of Cell Biology"},{"key":"8_CR59","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura, A., et al. (2001). Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 60, 759\u2013767.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"8_CR60","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan, R., & Reddy, P. H. (2017). Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. Journal of Alzheimer\u2019s Disease, 57, 975\u2013999.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"8_CR61","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.arr.2021.101529","volume":"73","author":"P Gowda","year":"2021","unstructured":"Gowda, P., Hemachandra Reddy, P., & Kumar, S. (2021). Deregulated mitochondrial microRNAs in Alzheimer\u2019s disease: Focus on synapse and mitochondria. Ageing Research Reviews, 73, 101529. https:\/\/doi.org\/10.1016\/j.arr.2021.101529","journal-title":"Ageing Research Reviews"},{"key":"8_CR62","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak, M., Calkins, M. J., & Reddy, P. H. (2011). Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: Implications for neuronal damage. Human Molecular Genetics, 20, 2495\u20132509.","journal-title":"Human Molecular Genetics"},{"key":"8_CR63","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1093\/hmg\/ddw312","volume":"25","author":"R Kandimalla","year":"2016","unstructured":"Kandimalla, R., et al. (2016). Reduced dynamin-related protein 1 protects against phosphorylated tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer\u2019s disease. Human Molecular Genetics, 25, 4881\u20134897.","journal-title":"Human Molecular Genetics"},{"key":"8_CR64","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","volume":"40","author":"S Forner","year":"2017","unstructured":"Forner, S., Baglietto-Vargas, D., Martini, A. C., Trujillo-Estrada, L., & LaFerla, F. M. (2017). Synaptic impairment in Alzheimer\u2019s disease: A dysregulated symphony. Trends in Neurosciences, 40, 347\u2013357.","journal-title":"Trends in Neurosciences"},{"key":"8_CR65","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E., et al. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell, 72, 971\u2013983.","journal-title":"Cell"},{"key":"8_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P., et al. (2015). Huntington disease. Nature Reviews Disease Primers, 1, 1\u201321.","journal-title":"Nature Reviews Disease Primers"},{"key":"8_CR67","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu, M., et al. (1996). Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Annals of Neurology, 39, 385\u2013389.","journal-title":"Annals of Neurology"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","volume":"61","author":"PH Reddy","year":"2009","unstructured":"Reddy, P. H., Mao, P., & Manczak, M. (2009). Mitochondrial structural and functional dynamics in Huntington\u2019s disease. Brain Research Reviews, 61, 33\u201348.","journal-title":"Brain Research Reviews"},{"key":"8_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui, L., et al. (2006). Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127, 59\u201369.","journal-title":"Cell"},{"key":"8_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver, P., & Spiegelman, B. M. (2003). Peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 (PGC-1\u03b1): Transcriptional coactivator and metabolic regulator. Endocrine Reviews, 24, 78\u201390.","journal-title":"Endocrine Reviews"},{"key":"8_CR71","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI27794","volume":"116","author":"BN Finck","year":"2006","unstructured":"Finck, B. N., & Kelly, D. P. (2006). PGC-1 coactivators: Inducible regulators of energy metabolism in health and disease. The Journal of Clinical Investigation, 116, 615\u2013622.","journal-title":"The Journal of Clinical Investigation"},{"key":"8_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","volume":"1049","author":"C Carmo","year":"2018","unstructured":"Carmo, C., Naia, L., Lopes, C., & Rego, A. C. (2018). Mitochondrial dysfunction in Huntington\u2019s disease. Advances in Experimental Medicine and Biology, 1049, 59\u201383. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_3","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"8_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","volume":"62","author":"A Johri","year":"2013","unstructured":"Johri, A., Chandra, A., & Beal, M. F. (2013). PGC-1\u03b1, mitochondrial dysfunction, and Huntington\u2019s disease. Free Radical Biology & Medicine, 62, 37\u201346.","journal-title":"Free Radical Biology & Medicine"},{"key":"8_CR74","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O., et al. (2017). Amyotrophic lateral sclerosis. Nature Reviews Disease Primers, 3, 17071.","journal-title":"Nature Reviews Disease Primers"},{"key":"8_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","volume":"13","author":"A Al-Chalabi","year":"2017","unstructured":"Al-Chalabi, A., Van Den Berg, L. H., & Veldink, J. (2017). Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nature Reviews. Neurology, 13, 96\u2013104.","journal-title":"Nature Reviews. Neurology"},{"key":"8_CR76","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80-.), 314, 130\u2013133.","journal-title":"Science (80-.)"},{"key":"8_CR77","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1212\/WNL.0b013e31828f18ac","volume":"80","author":"P Bede","year":"2013","unstructured":"Bede, P., et al. (2013). Cognitive changes predict functional decline in ALS: A population-based longitudinal study. Neurology, 80, 1590\u20131597.","journal-title":"Neurology"},{"key":"8_CR78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jnnp-2011-300188","volume":"83","author":"J Phukan","year":"2012","unstructured":"Phukan, J., et al. (2012). The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. Journal of Neurology, Neurosurgery, and Psychiatry, 83, 102\u2013108.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"8_CR79","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nature05290","volume":"443","author":"PT Lansbury","year":"2006","unstructured":"Lansbury, P. T., & Lashuel, H. A. (2006). A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature, 443, 774\u2013779.","journal-title":"Nature"},{"key":"8_CR80","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1111\/bph.12476","volume":"171","author":"H Muyderman","year":"2014","unstructured":"Muyderman, H., & Chen, T. (2014). Mitochondrial dysfunction in amyotrophic lateral sclerosis \u2013 A valid pharmacological target? British Journal of Pharmacology, 171, 2191\u20132205.","journal-title":"British Journal of Pharmacology"},{"key":"8_CR81","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/cells9041065","volume":"9","author":"M Kodavati","year":"2020","unstructured":"Kodavati, M., Wang, H., & Hegde, M. L. (2020). Altered Mitochondrial dynamics in motor neuron disease: An emerging perspective. Cell, 9, 1065.","journal-title":"Cell"},{"key":"8_CR82","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","volume":"97","author":"M Cozzolino","year":"2012","unstructured":"Cozzolino, M., & Carr\u00ec, M. T. (2012). Mitochondrial dysfunction in ALS. Progress in Neurobiology, 97, 54\u201366.","journal-title":"Progress in Neurobiology"}],"container-title":["Advances in Experimental Medicine and Biology","Understanding PTMs in Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-05460-0_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T07:09:18Z","timestamp":1700982558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-05460-0_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031054594","9783031054600"],"references-count":82,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-05460-0_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"28 August 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}